Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas A. Grigliatti is active.

Publication


Featured researches published by Thomas A. Grigliatti.


Molecular Genetics and Genomics | 1983

Genes which suppress position-effect variegation in Drosophila melanogaster are clustered

Donald A. R. Sinclair; Randall C. Mottus; Thomas A. Grigliatti

SummaryWe have isolated more than 50 dominant suppressors and 3 dominant enhancers of position effect variegation in Drosophila melanogaster. To our surprise, genetic mapping studies revealed that the Su(var) mutations are not randomly dispersed throughout the genome of this organism. Rather they fall into very discrete clusters. Moreover, all of the induced Su(var) mutations which map to a major second chromosome cluster are recessive lethal, whereas all of those which map within any of several third chromosome clusters are viable. Complementation analysis involving Su(var) mutations located within the 2L cluster suggests that several different loci occupy this site. Thus, these clusters may represent groupings of functionally related but distinct Su(var) loci.A subset of the suppressors were examined for their effects on several different variegating rearrangements. The results suggest that the suppressing ability of the mutants is general. Interestingly, the effects of the suppressors in males appears to be highly dependent upon the presence of the Y chromosome. Finally, examination of the Su(var) mutants at different developmental temperatures indicated that at least one of them is temperature-sensitive. These findings are discussed with respect to the potential for genetic and functional dissection of loci which encolde chromosomal components.


Gene | 1997

Baculovirus immediate-early promoter-mediated expression of the Zeocin™ resistance gene for use as a dominant selectable marker in Dipteran and Lepidopteran insect cell lines

Tom A. Pfeifer; Dwayne D Hegedus; Thomas A. Grigliatti; David A. Theilmann

The antibiotic Zeocin, a derivative of phleomycin, was evaluated for use as a selection system in both dipteran and lepidopteran insect cell lines. Growth of Drosophila cell lines, Kc1 and SL2, was inhibited at Zeocin concentrations of 50 and 75 microg/ml, respectively, while the Spodoptera cell line, Sf9, was inhibited at a concentration of 250 microg/ml Zeocin. The mammalian cytomegalovirus (CMV) and Simian virus 40 (SV40) early promoters did not function in these insect cell lines. Several baculovirus-derived immediate-early (IE) promoters from the Orgyia pseudotsugata multicapsid nucleopolyhedrovirus (OpMNPV) and Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) were used to drive expression of the Zeocin resistance gene (ble) in these cell lines. The resulting plasmid vectors enabled selection of Zeocin-resistant cell lines within 3-4 weeks. Gene amplification events in the presence of increasing Zeocin concentrations were not detected using Southern blot analysis. Furthermore, the function of the baculovirus IE promoters, as demonstrated by beta-galactosidase expression, was not detectable in a variety of mammalian cell lines tested. A cloning/shuttle vector, containing ten unique restriction sites, was constructed which allows for selection of Zeocin resistance in insect cell lines and in Escherichia coli.


Genetics | 1983

Histone gene multiplicity and position-effect variegation in Drosophila melanogaster

Gerald D. Moore; Donald A. R. Sinclair; Thomas A. Grigliatti

The histone genes of wild-type Drosophila melanogaster are reiterated 100-150 times per haploid genome and are located in the segment of chromosome 2 that corresponds to polytene bands 39D2-3 to E1-2. The influence of altered histone gene multiplicity on chromatin structure has been assayed by measuring modification of the gene inactivation associated with position effect variegation in genotypes bearing deletions of the 39D-E segment. The proportion of cells in which a variegating gene is active is increased in genotypes that are heterozygous for a deficiency that removes the histone gene complex. Deletions that remove segments adjacent to the histone gene complex have no effect on the expression of variegating genes. Suppression of position effect variegation associated with reduction of histone gene multiplicity applies to both X-linked and autosomal variegating genes. Position effects exerted by both autosomal and sex-chromosome heterochromatin were suppressible by deletions of the histone gene complex. The suppression was independent of the presence of the Y chromosome. A deficiency that deletes only the distal portion of the histone gene complex also has the ability to suppress position effect variegation. Duplication of the histone gene complex did not enhance position effect variegation. Deletion or duplication of the histone gene complex in the maternal genome had no effect on the extent of variegation in progeny whose histone gene multiplicity was normal. These results are discussed with respect to current knowledge of the organization of the histone gene complex and control of its expression.


Gene | 1998

A series of broad host range shuttle vectors for constitutive and inducible expression of heterologous proteins in insect cell lines

Dwayne D Hegedus; Tom A. Pfeifer; Jerrod Hendry; David A. Theilmann; Thomas A. Grigliatti

A series of shuttle vectors have been constructed that allow expression of heterologous proteins in either dipteran or lepidopteran insect cell lines. Constitutive expression in a broad range of host cells is mediated by the Orgyia pseudotsugata multicapsid nucleopolyhedrosis virus (OpMNPV) immediate-early 2 (ie2) promoter. Alternatively, if inducible expression is required, for example to express cytotoxic proteins, a vector has been constructed that uses the Drosophila metallothionein (Mtn) promoter for metal-inducible protein expression in dipteran cell lines. A chimeric synthetic bacterial-OpMNPV ie promoter-Zeocin resistance gene cassette has been included to facilitate cloning in E. coli as well as the generation of stably transformed insect cell lines. The utility of the system is demonstrated by the constitutive and inducible expression of the highly processed glycosylphosphatidylinositol-anchored glycoprotein, human melanotransferrin, in transformed insect cell lines.


Journal of Pharmacology and Experimental Therapeutics | 2010

Naturally Occurring Variants of Human Aldo-Keto Reductases with Reduced In Vitro Metabolism of Daunorubicin and Doxorubicin

Onkar S. Bains; Thomas A. Grigliatti; Ronald E. Reid; K. Wayne Riggs

Doxorubicin (DOX) and daunorubicin (DAUN) are effective anticancer drugs; however, considerable interpatient variability exists in their pharmacokinetics. This may be caused by altered metabolism by nonsynonymous single-nucleotide polymorphisms (ns-SNPs) in genes encoding aldo-keto reductases (AKRs) and carbonyl reductases. This study examined the effect of 27 ns-SNPs, in eight human genes, on the in vitro metabolism of both drugs to their major metabolites, doxorubicinol and daunorubicinol. Kinetic assays measured metabolite levels by high-performance liquid chromatography separation with fluorescence detection using purified, histidine-tagged, human wild-type, and variant enzymes. Maximal rate of activity (Vmax), substrate affinity (Km), turnover rate (kcat), and catalytic efficiency (kcat/Km) were determined. With DAUN as substrate, variants for three genes exhibited significant differences in these parameters compared with their wild-type counterparts: the A106T, R170C, and P180S variants significantly reduced metabolism compared with the AKR1C3 wild-type (Vmax, 23–47% decrease; kcat, 22–47%; kcat/Km, 38–44%); the L311V variant of AKR1C4 significantly decreased Vmax (47% lower) and kcat and kcat/Km (both 43% lower); and the A142T variant of AKR7A2 significantly affected all kinetic parameters (Vmax and kcat, 61% decrease; Km, 156% increase; kcat/Km, 85% decrease). With DOX, the R170C and P180S variants of AKR1C3 showed significantly reduced Vmax (41–44% decrease), kcat (39–45%), and kcat/Km (52–69%), whereas the A142T variant significantly altered all kinetic parameters for AKR7A2 (Vmax, 41% decrease; kcat, 44% decrease; Km, 47% increase; kcat/Km, 60% decrease). These findings suggest that ns-SNPs in human AKR1C3, AKR1C4, and AKR7A2 significantly decrease the in vitro metabolism of DOX and DAUN.


Molecular Genetics and Genomics | 1980

Butyrate suppression of position-effect variegation in Drosophila melanogaster

R. Reeves; R. Mottus; Thomas A. Grigliatti

SummaryThe strain of Drosophila melanogaster carrying the inversion In(1)wm4, which juxtaposes the normal w+ gene to the centromeric heterochromatin, variegates for pigmentation in the eye. This strain was treated with various concentrations of n-butyrate and n-proprionate during the embryonic and larval stages. Concentrations as low as 70mM markedly suppress the variegated eye phenotype. This suggests that non-acetylated histones play a major role in the phenomenon of position-effect variegation.


Chromosoma | 1990

Chromosomal structure is altered by mutations that suppress or enhance position effect variegation

Shizu Hayashi; A. Ruddell; David A. Sinclair; Thomas A. Grigliatti

We examined the genetic, morphological, and molecular effects of position effect variegation inDrosophila, and the effects of mutations that either suppress [Su(var)] or enhance [E(var)] this phenomenon. All eightSu(var) mutations examined strongly suppress the inactivation of variegating alleles of the genes white [In(l) wm4], brown [In (2R)bwVDe2] and Stubble [T(2;3)SbV]. TheE(var) mutation enhances variegation of these loci. The chromosomal region 3C-E (26 bands) which includes the white locus is usually packaged as heterochromatin in salivary glands of the variegating strainwm4. Addition of any of theSu(var) mutations restores a more euchromatic morphology to this region. In situ hybridization to polytene chromosomes and DNA blot analyses of gene copy number demonstrate that the DNA of thew+ gene is less accessible to its probe in the variegatingwm4 strain than it is in the wildtype or variegation-suppressed strains. Blot analysis of larval salivary gland DNA indicates that the white gene copy number does not vary among the strains. Hence, the differences in binding of thew+ gene probe in the variegating and variegation-suppressed strains reflect differences in chromosomal packaging rather than alterations in gene number. The effects of variegation and theSu(var) mutations on chromatin structure were analyzed further by DNAse I digestion and DNA blot hybridization. In contrast to their dramatic effects on chromosomal morphology and gene expression, theSu(var) mutations had negligible effects on nuclease sensitivity of the white gene chromatin. We suggest that the changes in gene expression resulting from position effect variegation and the action of theSu(var) mutations involve alterations in chromosomal packaging.


Drug Metabolism and Disposition | 2009

Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin

Onkar S. Bains; Morgan J. Karkling; Thomas A. Grigliatti; Ronald E. Reid; K. Wayne Riggs

Carbonyl reductases (CBRs) are a group of metabolic enzymes belonging to the short-chain dehydrogenase family with NADPH-dependent oxidoreductase activity. These enzymes are known to metabolize the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN). Both DOX and DAUN are highly effective in cancer therapy; however, there is considerable interpatient variability in adverse effects seen in patients undergoing treatment with these drugs. This may be attributed to altered metabolism associated with nonsynonymous single nucleotide polymorphisms (ns-SNPs) in the genes encoding for CBRs. In this study, we examine the effect of the V88I and P131S mutations in the human CBR1 gene on the metabolism of anthracyclines to their respective major metabolites, doxorubicinol and daunorubicinol. Kinetic studies using purified, histidine-tagged, recombinant enzymes in a high-performance liquid chromatography-fluorescence assay demonstrated that the V88I mutation leads to a significantly reduced maximal rate of activity (Vmax) (2090 ± 112 and 257 ± 11 nmol/min · mg of purified protein for DAUN and DOX, respectively) compared with that for the wild-type (3430 ± 241 and 364 ± 37 nmol/min · mg of purified protein for DAUN and DOX, respectively). In the case of the P131S mutation, a significant increase in substrate affinity (Km) was observed for DAUN only (89 ± 13 μM) compared with that for the wild-type (51 ± 13 μM). In the presence of either anthracycline, both variants exhibited a 20 to 40% decrease in catalytic efficiency (kcat/Km) compared with that for the wild-type enzyme. Therefore, the ns-SNPs generating both these mutations may alter bioavailability of these anthracyclines in cancer patients and should be examined in clinical studies as potential biomarkers for DAUN- and DOX-induced adverse effects.


Molecular Genetics and Genomics | 2006

Identification of three histone methyltransferases in Drosophila: dG9a is a suppressor of PEV and is required for gene silencing

Jacek Mis; Sarbjit S. Ner; Thomas A. Grigliatti

Organization of chromatin structure and regulation of gene transcription are contingent on histone tail modifications. Regions of the genome packaged with nucleosomes that contain methyl histone H3 at lysine 9 (Me K9H3) strongly correlate with regions that are silenced for transcription. To date Su(var)3-9 is the only K9H3 specific enzyme characterized in Drosophila melanogaster. In this study, we describe the identification of three additional Drosophila genes that potentially encode K9H3 specific methyltransferases (HMTase) with homology to known mammalian proteins. By several criteria, including sequence alignments, phylogenic analyses, and enzyme activity of the protein, one of these is a homologue of the human G9a and hence, we name it dG9a. dG9a catalyzes the transfer of methyl groups to full-length histone H3 and to N-terminal H3 peptides that contain lysine 9, suggesting that the major target for dG9a is K9H3. Chromatin extracts prepared from a P-element insert mutation in dG9a display an altered K9H3 methylation profile. In addition, the dG9a mutant is a dominant suppressor of position-effect variegation (PEV), a heterochromatin-associated gene silencing phenomenon. Su(var)3-9 also suppresses PEV. The combined Su(var)3-9 and dG9a mutations have severe developmental defects suggesting an overlapping role for dG9a and Su(var)3-9 in the packaging of heterochromatin and gene silencing via a K9H3 methylation pathway.


Molecular Genetics and Genomics | 1989

Characterization of mutations that enhance position-effect variegation in Drosophila melanogaster

Donald A. R. Sinclair; Vett K Lloyd; Thomas A. Grigliatti

SummarySeveral mutants that enhance the gene inactivation associated with position-effect variegation [E(var) mutants] have been characterized. These include three ethyl methanesulfonate (EMS)-induced lesions and a second chromosome duplication. Each of the EMS mutations maps to a discrete euchromatic site on the third chromosome. One is located within the chromosomal region occupied by a cluster of Su(var) mutations. All four E(var) mutants enhance the inactivation of several different variegators and therefore they appear to influence position-effect variegation generally. However, the enhancement caused by the single site E(var) mutations is less striking than that caused by the duplication or by loss of the Y chromosome. The interaction between the E(var) mutants and selected Su(var) mutations, as well as the effects of extra Y heterochromatin on E(var) expression, have also been investigated. Based on the results of these studies, various hypothetical functions of the E(var)+ products are suggested.

Collaboration


Dive into the Thomas A. Grigliatti's collaboration.

Top Co-Authors

Avatar

Tom A. Pfeifer

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Donald A. R. Sinclair

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

David T. Suzuki

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Ronald E. Reid

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Onkar S. Bains

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

K. Wayne Riggs

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Vett K Lloyd

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Randy Mottus

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Robert H. Devlin

Fisheries and Oceans Canada

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge